Celldex Therapeutics reported $0 in Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Agenus AGEN:US USD 13.46M 241K
Amgen AMGN:US USD 38.7B 2.18B
Applied Genetic Technologies AGTC:US USD 16.34M 2.08M
Aptinyx Inc APTX:US USD 24.71M 211K
Biocept BIOC:US USD 1.44M 1.1M
Bristol Myers Squibb BMY:US USD 39.1B 2.96B
Cytrx CYTR:US USD 0 0
Glaxosmithkline GSK:US GBP 22.12B 4M
Northwest Biotherapeutics NWBO:US USD 26.11M 339K
Rigel Pharmaceuticals RIGL:US USD 39.47M 9.63M